Personalized Nutrition to Improve Recovery in Trauma
Launched by DUKE UNIVERSITY · Sep 27, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special nutrition plan to help patients recover better after they have had abdominal surgery due to trauma. The trial is looking at whether a particular method, called the SeND Home pathway, which includes nutrition delivered through an IV, oral nutrition supplements (like shakes), and a device to measure calorie needs, can improve recovery for patients in the intensive care unit (ICU). Participants will be randomly assigned to either the SeND Home program or the standard nutrition care that is typically provided in the hospital. Both groups will undergo tests to check their energy use, body composition, muscle mass, and will also complete walking and strength tests as well as surveys about their quality of life.
To be eligible for this study, participants must be at least 18 years old and have experienced serious abdominal trauma that required emergency surgery. They also need to be in the surgical ICU and unable to eat by mouth for at least 72 hours. However, patients who cannot walk, those expected to stop life-sustaining treatment soon, prisoners, and women who are pregnant cannot participate. Those who join the study can expect close monitoring of their recovery and nutrition needs, which may help improve their overall healing process after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18+ years old
- • Penetrating abdominal trauma requiring emergent major abdominal surgery
- • Admitted to the surgical ICU
- • Not expected to receive oral nutrition for 72 hours or more
- Exclusion Criteria:
- • Patients who are unable to ambulate at baseline
- • Expected withdrawal of life-sustaining treatment within 48 hours
- • Prisoners
- • Positive pregnancy test for women of child bearing potential.
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Paul Wischmeyer, MD
Principal Investigator
Duke
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported